✨️Excellent 🆕️review ✨️
Resistance in Pseudomonas aeruginosa: A Narrative Review of Antibiogram* Interpretation and Emerging Treatments
EnJoy #IDXposts#MedEd
Antibiogram= Susceptibility report
Ex: oprD loss of function/downregulation Antibiogram👇 https://t.co/hI5ZMUBCD4
Levofloxacin is less active against SM than either TMP/SMX or minocycline, and its role in treatment of minor infections is doubtful given the potential for the emergence of resistance during therapy #IDXposts#MedEd
For non ID colleagues and ID ICYMI
these are the most important updates that you must know about the new CLSI "M100-Ed33"!
Updated Aminoglycoside Breakpoints for Enterobacterales & Pseudomonas aeruginosa
Background & Reasons for the Changes!
🌟Bookmark🌟
https://t.co/oZGlcidYqw
Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections
✅ Just Accepted
🆓 Freely Available
🔗 https://t.co/1DC5p1m0CF
【Early switch to oral antimicrobials in brain abscess: A narrative review】@CMIJournal Apr 27, 2023 🇩🇰
👉Great overview of studies describing use of early transition to PO in brain abscess! (Table 1)
https://t.co/Lr62Ja7TP8
@UT_Infectious#IDMedEd#IDFellow
Hot off the Press: New @CLSI_LabNews M100 Susceptibility Testing Reference now available! 🧫
Major update for aminoglycosides! Just in time for those annual antibiogram updates 🤓
Explore additional updates here: https://t.co/Y7b2nUd0ZG
1)There is a predictable rate of newly reported antibiotic “allergies” that will occur after all antibiotic use. Sulfonamides > penicillins > cephalosporins, macrolides, quinolones, clindamycin. #ASPchat Clinical Pearls
Pharmacodynamics, Mechanisms of Action and Resistance, and Spectrum of Activity of New Antifungal Agents
New review from Nathan Wiederhold of the Fungus Testing Laboratory at UTHSA
https://t.co/mBhdUIGbtd
Given the popularity of the Shorter Is Better website, and the need to move ID to oral Abx for better patient care, I've added a new webpage: oral Abx tables/references for osteo, bacteremia, endocarditis. Would love feedback. Am I missing studies? https://t.co/F9Whl43PhE
NEW 🔥🔥 #CID@eliowa et Al
Comparative Effectiveness of Switching to Daptomycin Versus Remaining on Vancomycin Among Patients With (MRSA) BSI
Switching to dapto within 3 days of initial receipt of vanco is associated with ⬇️ 30-day mortality #IDTwitter https://t.co/LmGwbCOrc3